CAS 1093070-16-6

GRL0617

CAS: 1093070-16-6

GRL0617 is a selective and competitive SARS-CoVPLpro and deubiquitinase noncovalent inhibitor(IC50 : 0.6 μM, Ki : 0.49 μM).

Formula: C₂₀H₂₀N₂O

Purity: 99.31%

Color and Shape: Solid

Molecular weight: 304.39

Ref: TM-T11464

GRL0617

CAS: 1093070-16-6

Formula: C₂₀H₂₀N₂O

Purity: 99%

Color and Shape: Solid

Molecular weight: 304.3856

Ref: IN-DA01KKBV

GRL0617

CAS: 1093070-16-6

GRL0617

Formula: C₂₀H₂₀N₂O

Purity: ≥98%

Molecular weight: 304.39

Ref: 54-BUP12825

GRL 0617

CAS: 1093070-16-6

A novel non-covalent inhibitor of the PLpro protease from SARS-CoV-2 and SARS-CoV viruses. GRL 0617 inhibits the proteolytic processing of the viral polypeptide. As PLpro also acts as a protease in pathways involved in innate immunity, there are indications that it can promote immunity against the virus.

Formula: C₂₀H₂₀N₂O

Purity: Min. 98 Area-%

Color and Shape: Powder

Molecular weight: 304.39 g/mol

Ref: 3D-BG178727

GRL0617

CAS: 1093070-16-6

(R)-5-amino-2-methyl-N-(1-(naphthalen-1-yl)ethyl)benzamide

Formula: C₂₀H₂₀N₂O

Purity: 99%

Molecular weight: 304.39

Ref: IN-DG01200315